CLEARSIDE BIOMEDICAL
Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of therapeutic products through an ocular microinjection platform that targets the individual compartments of the eye. It provides a non-surgical application for dosing drugs to distinct eye tissues, such as the retina, trabecular meshwork, and corneal stroma. The company’s CLS1001 is under development for retinal applications through the delivery of therapeutics to the suprachoroidal space. Clearside BioMedical was incorporated in 2011 and is based in Atlanta, Georgia.
CLEARSIDE BIOMEDICAL
Industry:
Biotechnology Health Care Medical Device Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Alpharetta, Georgia, United States
Country:
United States
Website Url:
http://www.clearsidebio.com
Total Employee:
11+
Status:
Active
Contact:
(678)270-3631
Total Funding:
188.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Global Site Tag
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2012-01-01
Board_member
Board_member
2011-01-01
Current Employees Featured
Henry F. Edelhauser Vice President, Scientific Affairs @ Clearside Biomedical
Vice President, Scientific Affairs
Charlie Deignan CFO @ Clearside Biomedical
CFO
2012-01-01
Thomas Ciulla Chief Medical Officer and Chief Development Officer @ Clearside Biomedical
Chief Medical Officer and Chief Development Officer
2020-03-01
Henry F. Edelhauser Founder @ Clearside Biomedical
Founder
Leslie Zacks General Counsel & Chief Compliance Officer @ Clearside Biomedical
General Counsel & Chief Compliance Officer
2018-09-01
Susan L. Coultas Chief Clinical Officer @ Clearside Biomedical
Chief Clinical Officer
2022-06-01
George Lasezkay President and Chief Executive Officer @ Clearside Biomedical
President and Chief Executive Officer
2020-03-01
Mark Prausnitz Scientific Founders @ Clearside Biomedical
Scientific Founders
2011-01-01
Founder
Stock Details
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Post-IPO Debt - Clearside Biomedical
RMI Partners
RMI Partners investment in Funding Round - Clearside Biomedical
Aju IB Investment
Aju IB Investment investment in Series C - Clearside Biomedical
Rock Springs Capital
Rock Springs Capital investment in Series C - Clearside Biomedical
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Clearside Biomedical
Perceptive Advisors
Perceptive Advisors investment in Series C - Clearside Biomedical
Mountain Group Capital
Mountain Group Capital investment in Series B - Clearside Biomedical
RMI Partners
RMI Partners investment in Series B - Clearside Biomedical
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - Clearside Biomedical
Georgia Research Alliance
Georgia Research Alliance investment in Series B - Clearside Biomedical
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-14 | Clearside Biomedical Expands Leadership Team with Appointment of Susan Coultas, Ph.D., as Chief Clinical Officer |
Official Site Inspections
http://www.clearsidebio.com Semrush global rank: 1.15 M Semrush visits lastest month: 27.52 K
- Host name: 212.87.134.34.bc.googleusercontent.com
- IP address: 34.134.87.212
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Clearside Biomedical"
Corporate Overview – Clearside Biomedical
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®). Our SCS Microinjector® enables an in-office, repeatable, non …See details»
Clearside Biomedical
Clearside Biomedical clearsidebio 2025-03-12T15:10:50+00:00. Explore Our CLS-AX Wet AMD Phase 3 Program Using Suprachoroidal Delivery. Explore Our CLS-AX Wet AMD Phase 3 Program Using Suprachoroidal Delivery. LEARN …See details»
Investor Overview | Clearside Biomedical, Inc.- IR Site
Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS ®) to improve patient …See details»
Clearside Biomedical, Inc. | LinkedIn
#ClearsideBio will report fourth quarter and full year 2024 financial results on Thursday, March 27, 2025 at 4:30pm ET. A webcast and conference call will be held to discuss the results and ...See details»
Clearside Biomedical - Crunchbase Company Profile
Contact Email info@clearsidebio.com Phone Number (678)270-3631 Clearside BioMedical, an ophthalmic company, specializes in the research, …See details»
Clearside Biomedical - LifeScienceHistory.com
Clearsidebio.com. 900 North Point Parkway, Suite 200. Alpharetta, GA 30005. Company Info Phone (678) 270-3631 Year Established 2011 Ticker CLSD Exchange NASDAQ. Contacts …See details»
Clearside Biomedical, Inc. Overview | SignalHire Company Profile
Organization Website: clearsidebio.com : Social Links: Phone Number: 1-678-270-3631: Clearside Biomedical... industries Biotech, Pharmaceuticals: Headquarters Location: 900 …See details»
Clearside BioMedical Inc Company Profile - Overview - GlobalData
Website clearsidebio.com Telephone 1 678 2703631. No of Employees 30. Industry Medical Equipment. Ticker Symbol & Exchange CLSD (NASD) Revenue (2023) $8.2M 519.9% (2023 …See details»
Clearside Biomedical - VentureRadar
"Clearside Biomedical, Inc., headquartered in Alpharetta, GA, is a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat chronic, blinding …See details»
Clearside Biomedical - Overview, News & Similar companies
May 9, 2024 Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024 ALPHARETTA, Ga., April 30, 2024 (GLOBE …See details»
Clearside Biomedical - Craft
Oct 29, 2024 Clearside Biomedical has 4 employees at their 1 location and $8.23 m in annual revenue in FY 2023. See insights on Clearside Biomedical including office locations, …See details»
Working At Clearside Biomedical: Company Overview and Culture
Www.clearsidebio.com. Organization Type. Public. Social Media. Clearside BioMedical, an ophthalmic company, specializes in the research, development, and commercialization of …See details»
Clearside Biomedical to Report Fourth Quarter and Full Year 2024 ...
ALPHARETTA, Ga., March 12, 2025 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD) (“Clearside” or the “Company”), a biopharmaceutical company revolutionizing …See details»
Clearside Biomedical
Mar 14, 2025 Clearside Biomedical was founded in 2011 in Alpharetta, Georgia to develop a novel, targeted treatment approach underpinned by a proprietary technological platform and …See details»
Rafael V. Andino - Clearside Biomedical, Inc. | LinkedIn
Aug 1, 2022 Rafael V. Andino is a biomedical engineer and businessman having 40 years of experience… · Experience: Clearside Biomedical, Inc. · Education: USAF Air War College · …See details»
Collaborations – Clearside Biomedical
Collaborations clearsidebio 2024-01-03T13:54:19+00:00 DEVELOPMENT AND COMMERCIALIZATION PARTNERS Our decision to selectively partner our proprietary …See details»
News Release Details - Clearside Biomedical, Inc.- IR Site
Feb 25, 2013 Santen researches, develops, and markets ophthalmic products worldwide. Santen has subsidiaries in the U.S., Europe, and Asia, including its wholly owned California …See details»
Clearside Biomedical, Inc. - Cruelty Free Investing
Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which develops drug therapies to treat chronic, blinding diseases of the eye, with a particular emphasis on diseases …See details»
News Release Details - ir.clearsidebio.com
Mar 6, 2025 For more information, please visit clearsidebio.com or follow us on LinkedIn and X. Cautionary Note Regarding Forward-Looking Statements. Any statements contained in this …See details»
News Release Details - Clearside Biomedical, Inc.- IR Site
Dec 31, 2021 ir@clearsidebio.com (678) 430-8206-Financial Tables Follow-CLEARSIDE BIOMEDICAL, INC. Selected Financial Data (in thousands, except share and per share data) …See details»